XII International HIV Drug Resistance Workshop, Los Cabos, Mexico, 10-14 June 2003
1 September 2003. Related: Conference reports, Drug resistance.
Intl Drug Resistance Workshop 12 Mexico 2003
Transmission of drug resistance – at 11% in Europe and 17% in the UK
1 September 2003. Related: Conference reports, HIV prevention and transmission, Drug resistance.
HIV coinfection, reinfection and superinfection
1 September 2003. Related: Conference reports, Hepatitis coinfection, HIV prevention and transmission, Drug resistance.
Single-dose nevirapine resistance in over 75% of mothers
1 September 2003. Related: Conference reports, Women's health, Pregnancy, Drug resistance.
Transmission of drug resistant virus does not revert to wild-type and does not appear ‘less fit’
1 September 2003. Related: Conference reports, Drug resistance.
Standard genotype assays may miss 75% of mutations when present in less than 35% of plasma sample
1 September 2003. Related: Conference reports, Drug resistance.
Low-level resistance and minority populations: cross resistance between nevirapine and efavirenz occurs even in the absence of genotypic mutations found using population sequencing
1 September 2003. Related: Conference reports, Drug resistance.
Persistent effect of d4T and 3TC, but not NNRTIs in the presence of associated genotypic mutations
1 September 2003. Related: Conference reports, Drug resistance.
Replicative capacity results complicated by minority wild-type virus
1 September 2003. Related: Conference reports, Virology, Drug resistance.
Response to STI is determined by virus rather than immunological response
1 September 2003. Related: Conference reports, Drug resistance.
Why resistance rarely develops with viral suppression <50 copies/mL
1 September 2003. Related: Conference reports, Drug resistance.
Long-term persistence of distinct mutations in genital tract
1 September 2003. Related: Conference reports, Women's health, Drug resistance.